id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-N-0314-0060,FDA,FDA-2007-N-0314,"Ozone Depleting Substances, Epinephrine; OMB Changes, Executive Order 12866 (E.O.) - Reference",Supporting & Related Material,REF-Reference (internal unless indicated),2008-11-24T05:00:00Z,2008,11,,,2008-12-21T02:10:24Z,,0,0,09000064807be656
FDA-2007-N-0314-0059,FDA,FDA-2007-N-0314,Ref. 17- HHS 71 FR 3848 Notice; Annual Update of the HHS Poverty Guidelines - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044],Supporting & Related Material,BKG-Background Material,2008-11-19T05:00:00Z,2008,11,,,2008-12-21T02:10:25Z,,0,0,09000064807afff4
FDA-2007-N-0314-0045,FDA,FDA-2007-N-0314,Ref. 1- National Center for Health Statistics - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044],Supporting & Related Material,BKG-Background Material,2008-11-19T05:00:00Z,2008,11,,,2008-12-21T02:10:29Z,,0,0,09000064807afefa
FDA-2007-N-0314-0053,FDA,FDA-2007-N-0314,"Ref. 11 -  US EPA Final Rule, 71FR58504 - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]",Supporting & Related Material,BKG-Background Material,2008-11-19T05:00:00Z,2008,11,,,2008-12-21T02:10:26Z,,0,0,09000064807aff97
FDA-2007-N-0314-0047,FDA,FDA-2007-N-0314,"Ref. 3 - Global Strategy for Asthma Management & Prevention, Global Initiative for Asthma - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]",Supporting & Related Material,BKG-Background Material,2008-11-19T05:00:00Z,2008,11,,,2008-12-21T02:10:28Z,,0,0,09000064807aff2b
FDA-2007-N-0314-0048,FDA,FDA-2007-N-0314,Ref. 4 - United Nations Environmental Programme - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044],Supporting & Related Material,BKG-Background Material,2008-11-19T05:00:00Z,2008,11,,,2008-12-21T02:10:28Z,,0,0,09000064807aff3d
FDA-2007-N-0314-0052,FDA,FDA-2007-N-0314,Ref. 10 - Analysis Completed by FDA Based on Retail Sales Data from ACNielson - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044],Supporting & Related Material,BKG-Background Material,2008-11-19T05:00:00Z,2008,11,,,2008-12-21T02:10:27Z,,0,0,09000064807aff90
FDA-2007-N-0314-0054,FDA,FDA-2007-N-0314,"Ref.12 - Rozek, R. P. and Bishko, E.R., Economics Issues Raised in the FDA's Proposed Rule - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]",Supporting & Related Material,BKG-Background Material,2008-11-19T05:00:00Z,2008,11,,,2008-12-21T02:10:26Z,,0,0,09000064807affb3
FDA-2007-N-0314-0046,FDA,FDA-2007-N-0314,Ref. 2- Expert Panel Report 3: Guidelines for the Diagnosis & Management of Asthma - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044],Supporting & Related Material,BKG-Background Material,2008-11-19T05:00:00Z,2008,11,,,2008-12-21T02:10:29Z,,0,0,09000064807aff10
FDA-2007-N-0314-0051,FDA,FDA-2007-N-0314,"Ref. 7 - American Lung Association, Trends in Asthma Morbidity and Mortality - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]",Supporting & Related Material,BKG-Background Material,2008-11-19T05:00:00Z,2008,11,,,2008-12-21T02:10:27Z,,0,0,09000064807aff62
FDA-2007-N-0314-0056,FDA,FDA-2007-N-0314,"Ref. 14 - Gal, A., and N.R. Chari, Phase Out CFC Albuterol Production by Early 2007 - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]",Supporting & Related Material,BKG-Background Material,2008-11-19T05:00:00Z,2008,11,,,2008-12-21T02:10:25Z,,0,0,09000064807affcf
FDA-2007-N-0314-0057,FDA,FDA-2007-N-0314,"Ref. 15 - Berger, W. E. et al., The Utility of the Health Plan Employer Data & Information Set - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]",Supporting & Related Material,BKG-Background Material,2008-11-19T05:00:00Z,2008,11,,,2008-12-21T02:10:25Z,,0,0,09000064807affdd
FDA-2007-N-0314-0044,FDA,FDA-2007-N-0314,Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine) - Notice of Final Rule,Rule,NFR-Notice of Final Rule,2008-11-19T05:00:00Z,2008,11,2008-11-19T05:00:00Z,,2011-06-11T16:26:51Z,E8-27436,0,0,09000064807b155a
FDA-2007-N-0314-0049,FDA,FDA-2007-N-0314,"Ref. 5 - EPA, The Benefits & Costs of the Clean Air Act - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]",Supporting & Related Material,BKG-Background Material,2008-11-19T05:00:00Z,2008,11,,,2008-12-21T02:10:28Z,,0,0,09000064807aff4a
FDA-2007-N-0314-0050,FDA,FDA-2007-N-0314,"Ref. 6 - National Center for Health Statistics (March 28, 2007) - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]",Supporting & Related Material,BKG-Background Material,2008-11-19T05:00:00Z,2008,11,,,2008-12-21T02:10:27Z,,0,0,09000064807aff50
FDA-2007-N-0314-0055,FDA,FDA-2007-N-0314,Ref. 13 - Analysis Completed by FDA Based on Prescription Data Provided by IMS - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044],Supporting & Related Material,BKG-Background Material,2008-11-19T05:00:00Z,2008,11,,,2008-12-21T02:10:26Z,,0,0,09000064807affc4
FDA-2007-N-0314-0058,FDA,FDA-2007-N-0314,Ref.16 - Centers for Medicare and Medicaid Services - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044],Supporting & Related Material,BKG-Background Material,2008-11-19T05:00:00Z,2008,11,,,2008-12-21T02:10:25Z,,0,0,09000064807affeb
FDA-2007-N-0314-0016,FDA,FDA-2007-N-0314,"Background Material - CDC - ""Early Release of Selected Estimates Based on Data From the 2005 National Health Interview Survey""",Supporting & Related Material,BKG-Background Material,2008-08-11T04:00:00Z,2008,8,,,2008-08-11T17:10:28Z,,0,0,090000648042b724
FDA-2007-N-0314-0027,FDA,FDA-2007-N-0314,Background Material ' Medicaid At-a-GLance 2005 - A medicaid Information Source,Supporting & Related Material,BKG-Background Material,2008-08-11T04:00:00Z,2008,8,,,2008-08-11T18:24:35Z,,0,0,090000648042b746
FDA-2007-N-0314-0029,FDA,FDA-2007-N-0314,Background Material - Table of Contents to References for the Proposed Rule on Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine),Supporting & Related Material,BKG-Background Material,2008-08-11T04:00:00Z,2008,8,,,2008-08-11T18:24:37Z,,0,0,090000648042b748
FDA-2007-N-0314-0028,FDA,FDA-2007-N-0314,Background Material - FR - Annual Update of the HHS Poverty,Supporting & Related Material,BKG-Background Material,2008-08-11T04:00:00Z,2008,8,,,2008-08-11T18:24:36Z,,0,0,090000648042b747
FDA-2007-N-0314-0023,FDA,FDA-2007-N-0314,"Background Material - Analysis Completed by FDA based on Retail Sales Data from Drug Stores and Supermarkets Provided by ACNielsen for the 52 Weeks Ending September 9, 2006.",Supporting & Related Material,BKG-Background Material,2008-08-11T04:00:00Z,2008,8,,,2008-08-11T18:24:31Z,,0,0,090000648042b742
FDA-2007-N-0314-0020,FDA,FDA-2007-N-0314,"Background Material - ""National Healthcare Disparities Report"" - HHS",Supporting & Related Material,BKG-Background Material,2008-08-11T04:00:00Z,2008,8,,,2008-08-11T17:10:32Z,,0,0,090000648042b729
FDA-2007-N-0314-0021,FDA,FDA-2007-N-0314,"Background Material - ""The Benefits and Costs of the Clean Air Act 1990 to 2010"" EPA",Supporting & Related Material,BKG-Background Material,2008-08-11T04:00:00Z,2008,8,,,2008-08-11T17:51:12Z,,0,0,090000648042b73d
FDA-2007-N-0314-0018,FDA,FDA-2007-N-0314,Background Material,Supporting & Related Material,BKG-Background Material,2008-08-11T04:00:00Z,2008,8,,,2008-08-11T17:10:30Z,,0,0,090000648042b726
FDA-2007-N-0314-0025,FDA,FDA-2007-N-0314,Background Material - ECONOMIC ISSUES RAISEDIN THE FDA’S PROPOSED RULE ON Removing the Essential-Use Designation for Albuterol MDIs,Supporting & Related Material,BKG-Background Material,2008-08-11T04:00:00Z,2008,8,,,2008-08-11T18:24:33Z,,0,0,090000648042b744
FDA-2007-N-0314-0024,FDA,FDA-2007-N-0314,Background Material - FR Protection of Stratospheric Ozone...,Supporting & Related Material,BKG-Background Material,2008-08-11T04:00:00Z,2008,8,,,2008-08-11T18:24:32Z,,0,0,090000648042b743
FDA-2007-N-0314-0015,FDA,FDA-2007-N-0314,"Background Material - ""Annual Demographic Survey"" - Bureau of Labor Statistics & Bureau of the Census",Supporting & Related Material,BKG-Background Material,2008-08-11T04:00:00Z,2008,8,,,2008-08-11T16:25:30Z,,0,0,090000648042b71e
FDA-2007-N-0314-0022,FDA,FDA-2007-N-0314,Background Material - CDC - Asthma episodes and current asthma,Supporting & Related Material,BKG-Background Material,2008-08-11T04:00:00Z,2008,8,,,2008-08-11T17:51:13Z,,0,0,090000648042b73e
FDA-2007-N-0314-0026,FDA,FDA-2007-N-0314,"Background Material - Analysis Completed by FDA based on Prescription Data Provided by IMS Health, National Prescription Audit, 2004; IMS Health, IMS MIDAS (TM), Q1/2004–Q2/2004",Supporting & Related Material,BKG-Background Material,2008-08-11T04:00:00Z,2008,8,,,2008-08-11T18:24:34Z,,0,0,090000648042b745
FDA-2007-N-0314-0017,FDA,FDA-2007-N-0314,"Background Material - EXPERT PANEL REPORT 2 Guidelines for the Diagnosis and Management of Asthma""",Supporting & Related Material,BKG-Background Material,2008-08-11T04:00:00Z,2008,8,,,2008-08-11T17:10:29Z,,0,0,090000648042b725
FDA-2007-N-0314-0019,FDA,FDA-2007-N-0314,"Background Material - CDC/NCHS-""Asthma Prevalence, Health Care Use and Mortality, 2002""",Supporting & Related Material,BKG-Background Material,2008-08-11T04:00:00Z,2008,8,,,2008-08-11T17:10:31Z,,0,0,090000648042b728
FDA-2007-N-0314-0013,FDA,FDA-2007-N-0314,Background Material - Table of Contents to References for the Proposed Rule on Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine),Supporting & Related Material,BKG-Background Material,2008-08-05T04:00:00Z,2008,8,,,2008-08-05T14:02:31Z,,0,0,090000648042b715
FDA-2007-N-0314-0014,FDA,FDA-2007-N-0314,Background Material - Press Release:Alkermes Presents Positive Clinical Data for Inhaled Form of  Epinephrine,Supporting & Related Material,BKG-Background Material,2008-08-05T04:00:00Z,2008,8,,,2008-08-05T14:02:32Z,,0,0,090000648042b717